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Objective. The aim was to assess the intraperitoneal spread of endometrial cells during hysteroscopy. Study Design.S e v e n t y - s i x
women were submitted to a hysteroscopy with CO2 under a low pressure. Group 1 had not previous diagnosis of endometrial
cancer, and group 2 had previous diagnosis of endometrial cancer (stage I-92.3%). Two peritoneal washing samples were taken
before (PW1) and immediately after (PW2) the procedure. The dissemination for the peritoneal cavity was deﬁned by the
presence of endometrial cells in the PW2; such cells should be absent in WP1. Results. Four patients were excluded for presenting
endometrial cells in PW1. In the 72 patients left, there was no passage of cells for the peritoneal cavity. In group 1, 88% presented
secretoryendometrialphasewithcorrelationof80%betweenhysteroscopyandbiopsy.Conclusion.Hysteroscopyperformedunder
al o wp r e s s u r eo fC O 2 does not cause spreading of endometrial cells into the peritoneal cavity.
Copyright © 2009 Rievani de Sousa Dami˜ ao et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Hysteroscopy has been established as the gold standard
procedure to evaluate and to treat abnormal uterine bleeding
[1, 2]. The uterine cavity can be thoroughly visualized
a n da ne n d o m e t r i a lb i o p s ys p e c i m e nc a nb et a k e nu n d e r
hysteroscopic view [3, 4]. An endometrial carcinoma can be
detected in 7%–10% of postmenopausal patients and 2%-
3% of premenopausal patients submitted to hysteroscopy
[5, 6]. In view of these, hysteroscopy is now considered as an
importantmethodintheinvestigationofendometrialcancer
[3–6].
Hysteroscopy requires distention of the cavity with a
gaseous or liquid medium at a pressure of 50–150mmHg to
allow complete visualization of the fundus and ostial areas.
Liquid media used for this purpose include high-viscosity
ﬂuids such as 32% dextran 70 or low-viscosity ﬂuids such
as 5% dextrose, Ringer’s or normal saline solution. The
gas universally used for diagnostic hysteroscopy is carbon
dioxide (CO2). There is evidence from observational studies
that distension of uterine cavity could be associated with
transtubal leakage of endometrial cells and tissue reﬂux into
the peritoneal cavity [7–12]( Table 1).
It has also been demonstrated that liquid distention
appears to have a higher leakage of endometrial cells
compared to CO2 distention. On the other hand, there are
studies, looking at CO2 distention, that presented contradic-
tory results [7, 11, 13].
In fact, transtubal leakage of endometrial cell during
hysteroscopy is of concern when investigating women com-
plaining of abnormal uterine bleeding who are subsequently
found to have endometrial malignancy. Several investigators
have reported on retrograde seeding of endometrial carci-
noma during hysteroscopy [14–16]. However, these results
are controversial in view of diﬀerent pressure and method of
distention.
Although the clinical implication of such reﬂux has not
yet been determined, in principle, it would be avoided in
high-risk patients. The current evidence suggests that this
would be best achieved with gaseous distention rather than2 Obstetrics and Gynecology International
Table 1: Studies reporting on the association between hysteroscopy and positive peritoneal cytology where N: number of cases; PW:
peritoneal washing.
Author N Indication for
surgery
Hysteroscopy Laparoscopy
Distention Pressure Positive PW
Ranta et al. [7]5 1 Infertility CO2 80mmHg 8/51 (15.6%)
Sagawa et al. [8]2 4Endometrial cancer Glucose solution
or dextran
50cmH2O 2/24 (8.4%)
Leveque et al. [9]1 9 Endometrial cancer CO2 NaCl 0.9% (2
cases)
150mmHg 7/19 (36.8%)
G¨ ucer et al. [10]3 1Endometrial cancer NaCl 0.9% 200mmHg 3/31 (9.7%)
Lo et al. [11]7 0 Endometrial cancer CO2 100mmHg 1/70 (1.4%)
Lo et al. [11]5 0 Endometrial cancer NaCl 0.9% 100cmH2O 7/50 (14%)
Solima et al. [12]4 0 Endometrial cancer
(Stage I or II) NaCl 0.9% 40mmHg 2/40 (5%)
with liquid distention. To investigate the inﬂuence of the
uterine distention medium on tubal reﬂux, we conducted
a prospective longitudinal study using hysteroscopy with
CO2 at a pressure of 80mmHg (low-pressure hysteroscopy)
to assess the occurrence of eventual leakage of endometrial
cells into the peritoneal cavity in women with and without
endometrial cancer.
2.MaterialandMethods
Seventy-six patients were initially enrolled; sixty one under-
went laparoscopy for tubal sterilization or other indications
(group 1), and ﬁfteen required laparotomy due to endome-
trial cancer (group 2).
Theinclusioncriteriawerenormalreproductivefunction
with patent Fallopian tubes and no history of either tubal
disease or tubal surgery, over 3 months of oral contraceptive
use discontinuation, no history of pregnancy within the last
year. The exclusion criteria were peritoneal cytology positive
for endometrial cells after ﬁrst peritoneal washing (PW1)
and negative tubal patency test.
The study was carried out in a sequence of two stages.
In the initial stage, either laparoscopy (in group 1) or
laparotomy (in group 2) was performed, and peritoneal
cells were collected for cytology study (control sample)
by injecting 40mL of normal saline solution (PW1) in
the Douglas pouch, around the tubes and ovaries. When
laparotomy was performed, a syringe containing 40mL of
saline solution was used for injection and aspiration of the
peritoneal washing. When laparoscopy was performed, a
second puncture was performed where a 5mm Endopath
trocar (Johnson & Johnson) was used for injection and
aspiration of the peritoneal washing.
In the second stage, diagnostic hysteroscopy was per-
formed by a standard hysteroscope with a 30◦ forward-
oblique lens and 5mm diagnostic sheath. An electronic
Hamou hysteroﬂator (Karl Storz GmbH, Tuttingen, Ger-
many), adjusted to a ﬂow rate ≤50mL/min and pressure
≤80mmHg of CO2, was used to distend the intrauterine
cavity. All hysteroscopies were performed by the same
operator and lasted 4 minutes average. A second peritoneal
washing (PW2) was performed using the same technique
as that in stage one. Tubal patency was conﬁrmed after
the second sample was taken by transcervical injection
of 20mL methylene blue dye dilution through a cervical
cannula. A selective endometrial sampling by hysteroscopy
was performed immediately before PW2.
The two samples of the peritoneal washing (before
hysteroscopy-PW1; after hysteroscopy-PW2) were ﬁxed in
95% ethyl alcohol and centrifuged at 3000g for 10 minutes.
After being ﬁxed by Papanicolaou staining technique, the
samples were analyzed at 100× magniﬁcation. Cells were
assessed morphologically. Endometrial and tubal cells were
identiﬁed as nonciliated or ciliated epithelial cells, respec-
tively. In addition, the samples were studied in a blind
manner with respect to the diagnosis by an experienced
cytopathologist.
Positive peritoneal cytology was considered the primary
endpoint of this study. Frequency distribution of ordered
categorical variables was compared by means of exact
Wilcoxon rank-sum test. Correlations between dichotomous
variables were tested using Fisher’s exact test. The data were
analyzed using the chi-square test, and P-value of .05 was
consideredsigniﬁcant.Thestudywaspreviouslyapprovedby
the ethical committee.
3. Results
From the initial 76 patients, four (5.2%) were excluded due
to positive peritoneal cytology after PW1. Two of these had
endometrialcancer(stageIIIAG2),andtwowereinsecretory
phase of menstrual cycle. Therefore, 72 women participated,
of which 13 had endometrial cancer (18.0%), were labeled
group 2, and 59 who had no endometrial cancer (82.0%)
were labeled group 1.
The characteristics of all these patients are presented in
Tables 2 and 3. The previous diagnosis of endometrial cancer
had been made by hysteroscopy plus biopsy. The interval
time between diagnoses of cancer and surgery was 28 (24–
40) days.
Among patients of group 2, 11 (84.6%) were in the
postmenopausal phase and two (15.4%) in premenopausalObstetrics and Gynecology International 3
Table 2: Characteristics of patients with benign endometrial
cytology (group 1).
N %
Numbers of patients 59/72 81.9
Age years (range) 35 (17–41) —
Nulliparous 10 17.0
Laparoscopy indication
Tubal sterilization 36 61.0
Hysterectomy 14 23.7
Ovarian mass 6 10.2
Chronic pelvic pain 35 . 1
Phase of menstrual cycle
Secretory 52 88.1
Proliferative 7 11.9
Table 3: Characteristics of patients with cancer (group 2); group1:
<5% of a nonsquamous or nonmorular solid growth pattern;
group2: 6–50% of a nonsquamous or nonmorular solid growth
pattern.
N %
Number of patients 13/72 18.1
Age years (range) 57 (51–79) —
Hysteroscopy indication
Abnormal uterine bleeding 9 69.2
Abnormal thickness 4 30.8
Endometrial
Stages∗
IA1 5 38.4
IB2 3 23.1
IC1 3 23.1
IC2 17 . 7
IIIIC2 17 . 7
Corpus Cancer Staging according to FIGO Stages—1988 Revision.
phase. Hysteroscopy was indicated for abnormal vaginal
bleeding in nine cases (69.2%) and for abnormal sono-
graphic endometrial thickness in four cases (30.8%). The
majority of these patients had been staged as I (92.3%).
In both groups, there were no endometrial cells in
the second sample collected immediately after diagnostic
hysteroscopy.
4. Comment
The data of this study demonstrate that diagnostic hys-
teroscopy performed under a low pressure of CO2 does
not cause spreading of endometrial cells into the peritoneal
cavity for both patients with and without early stage of
endometrial cancer.
As hysteroscopy is largely indicated in patients with
abnormal uterine bleeding, it becomes relevant to demon-
strate whether this procedure is safe when underlying
endometrial cancer is suspected. Abnormal endometrial cells
reﬂux into the peritoneal cavity after diagnostic hysteroscopy
which has been reported in about 16% of cases might
increase the risk of recurrence [17, 18].
There is controversy regarding the potential dissemina-
tion of malignant endometrial cells into the peritoneal cavity
through the Fallopian tubes during diagnostic hysteroscopy.
However,retrospectivestudieshavesuggestedthatdiagnostic
hysteroscopy does not signiﬁcantly increase the incidence
of positive peritoneal cytology in patients with endometrial
cancer [17, 19].
Stage and grade of endometrium cancer, intrauterine
pressure, and the medium of distension used during the
hysteroscopy are thought to be related with the spreading
of malignant endometrial cells into the peritoneal cavity
[2, 3, 5, 15, 17, 20, 21]. Nevertheless, there is no prospective
study that could point at any of those factors as having a
signiﬁcant role in the spreading of malignant cells to the
abdominal cavity.
Early recurrence of endometrial cancer within one year
a f t e rs u r g i c a lt r e a t m e n th a sb e e nr e p o rt e da sb e i n gc a u s e db y
hysteroscopy dissemination of malignant cells [14–16]. The
most important factor associated with transtubal spreading
of endometrial cells during hysteroscopy procedure appears
to be the intrauterine pressure used. Baker and Adamson
[22] observed spreading of endometrial cell after diagnostic
hysteroscopy using high intrauterine pressure, and Bettocchi
et al. [23] have suggested that intrauterine pressure of
150mmHg has a higher risk for cell dissemination. Leveque
et al. [9] used intrauterine pressure of 150mmHg and
observed a positive peritoneal cytology in 37% of the
cases. In contrast, positive peritoneal cytology is seen in
about 1.0% when the intrauterine pressure was equal or
below 100mmHg [7, 8, 11, 12]. Baker and Adamson have
demonstrated that no spread of endometrial cell occurs at
intrauterine pressure equal or below 70mmHg [22]. The
main limitation of these studies was that the peritoneal
cytology was not taken at the same time as hysteroscopy or
as a previous cytology study before hysteroscopy.
Lo et al. [11] have also demonstrated that using a
liquid medium for intrauterine distension has a higher
association with positive peritoneal cytology after diagnostic
hysteroscopy(14%versus1.4%).Hence,theriskofspreading
cell into the peritoneal cavity is lower when this was done by
gaseous medium under a low pressure to distend the uterine
cavity [3, 10, 14, 16, 24].
In our study, we performed diagnostic hysteroscopy
using intrauterine pressure no greater than 80mmHg and
CO2 gas to distend the intrauterine cavity. Also, peritoneal
cytology was performed before as well as after hysteroscopy.
All included patients in the study had absent endometrial
cells in the ﬁrst washing. None of our cases showed positive
peritoneal cytology after hysteroscopy.
Inconclusion,diagnostichysteroscopyusingintrauterine
pressure no greater than 80mmHg and CO2 gas to distend
the intrauterine cavity appears to be a safe procedure in
high-risk patient for endometrial cancer. However, further
studies are required to assess endometrial cell spreading after
diagnostic hysteroscopy in diﬀerent stages of endometrial
cancer with long followup.4 Obstetrics and Gynecology International
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